Stay updated on Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Sign up to get notified when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page, replacing the previous content with an access-denied view. A Home button is presented on the error page.
    Difference
    0.5%
    Check dated 2026-09-27T07:51:02.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page for the study record URL, indicating access is blocked and displaying a 403 header and related message. The usual study details are not visible, replaced by the error screen with a Home option.
    Difference
    18%
    Check dated 2026-09-20T03:15:00.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor metadata update to the study record.
    Difference
    0.1%
    Check dated 2026-08-29T20:02:29.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The study record now lists the Study Chair and Investigators, including BioXcel Therapeutics personnel, and shows the latest update date of 2026-08-11. It also removes older update dates from 2023.
    Difference
    0.5%
    Check dated 2026-08-15T15:33:45.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the study page, indicating a minor update to the page’s content or layout rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-08-08T14:49:17.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.3 to v3.6.4, reflecting a system/template update rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-07-25T06:44:24.000Z thumbnail image

Stay in the know with updates to Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.